Litfulo (Ritlecitinib): A New Medicine for Hair Loss
Litfulo (Ritlecitinib)’s Effectiveness After 24 weeks of treatment, 23% of participants experienced 80% or more scalp hair coverage, compared to just 1.6% […]
PHARMA TRENDS: Upcoming Drugs
Trends in Medicine Approvals and FDA’s New Market Entries
A New Schizophrenia Treatment: KarXT
A New Schizophrenia Treatment: KarXT Schizophrenia, a severe, long-term mental health condition, affects approximately 1 in 300 people worldwide. The
Current Clinical Trials on Weight Loss in Progress: A 2024 Overview
Details of nine ongoing 2024 clinical trials on weight loss, managing obesity and its complications are listed in this page.
Wegovy: Financial Impact, Revenue and Stock Price Analysis
Wegovy: Financial Impact, Revenue and Stock Price Analysis Wegovy, a weight loss drug manufactured by Novo Nordisk, has made significant
Wegovy: Availability, Shortage and Side Effects
Wegovy, also known by its generic name semaglutide, is a prescription medication approved by the U.S. Food and Drug Administration
AVT02: A Promising Biosimilar Drug to Adalimumab (Humira)
Biosimilar drugs have emerged as a cost-effective alternative to their reference biologic counterparts. They offer the same therapeutic benefits while